JASON SANCHEZ: Open Payments
NPI 1871826966 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,962 in 251 payments from 20 companies in 2025. Trend: 2023 $8,278 · 2024 $4,732 · 2025 $3,962
Food & beverage: $3,962
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $796 |
| Incyte Corporation | 29 | $428 |
| GENZYME CORPORATION | 8 | $351 |
| UCB, Inc. | 15 | $334 |
| Galderma Laboratories, L.P. | 13 | $254 |
| Arcutis Biotherapeutics, Inc. | 26 | $240 |
| Janssen Biotech, Inc. | 25 | $226 |
| LEO Pharma Inc. | 14 | $222 |
| E.R. Squibb & Sons, L.L.C. | 15 | $196 |
| Regeneron Healthcare Solutions, Inc. | 5 | $163 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, Bimzelx, RINVOQ, Zoryve, NEMLUVIO, TREMFYA.
Industry payments across CA — which companies pay providers there.
